Veradermics, Incorporated (MANE) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Veradermics, Incorporated (MANE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $5.17B, listed on NYSE, employing roughly 21 people, carrying a beta of 0.77 to the broader market. Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. Led by Reid Waldman, public since 2026-02-04.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for MANE as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →